Why the study?
Does saralasin infusion affect blood pressure and renal hemodynamics differently before and after sodium depletion in hypertensive patients?
Does saralasin infusion affect blood pressure and renal hemodynamics differently before and after sodium depletion in hypertensive patients?
The hypotensive effect of angiotensin II blockade with saralasin is markedly enhanced by sodium depletion and correlates closely with baseline plasma renin activity, regardless of hypertension etiology.
Answers are grounded in this paper and cite their sources.
Sodium depletion may enhance saralasin response in hypertension; hypothesis-generating and should not yet change practice.
Angiotensin II blockade before and after marked sodium depletion in patients with hypertension [unilateral renovascular (eight), bilateral renovascular (four) and essential (four)] was performed by intravenous administration of the angiotensin II antagonist Sar1-Ala8-angiotensin II (saralasin). 2. On normal sodium intake, saralasin decreased mean blood pressure by 8 mmHg in the unilateral renovascular group, by 6 mmHg in the bilateral renovascular group and increased it by 3 mmHg in the essential hypertensive group. After sodium depletion saralasin decreased mean blood pressure by 33 mmHg, 35 mmHg and 18 mmHg respectively. The saralasin-induced decrease in blood pressure significantly correlated with the log of the initial plasma renin activity. 3. Saralasin infusion decreased effective renal plasma flow (ERPF) in all three hypertension subgroups, both on normal sodium intake and after sodium depletion. Glomerular filtration rate decreased in direct relation to the hypotensive effect of saralasin but ERPF showed this relationship only after sodium depletion. On normal sodium intake saralasin increased filtration fraction by 17%, but decreased it by 7% after sodium depletion. 4. It is concluded that the hypotensive action of saralasin closely correlates with the value of circulating plasma renin activity, apparently independent of the aetiology of the hypertension. The decrease in ERPF during saralasin infusion in the patients on normal sodium intake seems mainly related to the agonistic activity of saralasin, but that after sodium depletion to the hypotensive effect of saralasin.
No takes yet. Share an insight, caveat, or question.
Hoogdalem et al. (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: